Jefferies Downgrades Astellas Pharma to Hold From Buy, Adjusts Price Target to 1,700 Yen From 2,100 Yen
Jefferies Downgrades Astellas Pharma to Hold From Buy, Adjusts Price Target to 1,700 Yen From 2,100 Yen
Jefferies将安斯泰莱制药(adr)的评级从买入下调至持有，将目标价从2100日元下调至1700日元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间